Physician profile
Scott Adams
NPI 1013905785
$3,210.63
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $783 · 2020: $583 · 2021: $620 · 2022: $831 · 2023: $361 · 2024: $31.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $392.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $794.05 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $724.35 | 2019-2023 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $261.19 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $186.00 | 2019-2022 | |
| Novo Nordisk INC | $161.28 | 2019-2024 | Ozempic |
| Allergan, INC. | $156.26 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $145.73 | 2019-2023 | Farxiga |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $129.88 | 2019-2022 | |
| Pfizer INC. | $128.74 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $124.02 | 2023-2024 | Ilumya |
| Lilly USA, LLC | $100.76 | 2020-2022 | |
| Inspire Medical Systems, INC. | $86.49 | 2023 | Inspire |
| Amgen INC. | $28.97 | 2019 | |
| Horizon Therapeutics Plc | $27.60 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $24.68 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $21.78 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.96 | 2019 | |
| Eisai INC. | $17.59 | 2020 | |
| Astellas Pharma US INC | $17.00 | 2023 | Veozah |
| Idorsia Pharmaceuticals US INC | $15.78 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.62 | 2022 | |
| Genentech USA, INC. | $12.49 | 2021 | |
| Supernus Pharmaceuticals, INC. | $11.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.